J Korean Med Assoc.  2005 May;48(5):465-471. 10.5124/jkma.2005.48.5.465.

Guidelines for Clinical Management of Premenstrual Syndrome

• Choi DS

• KMID: 2183552
• DOI: http://doi.org/10.5124/jkma.2005.48.5.465

Abstract

Premenstrual syndrome(PMS) refers to a group of menstruation-related symptoms that impair daily activity and interpersonal relationship. The therapeutic modality for PMS consists of non-pharmacologic and pharmacologic treatment. Generally, after confirmation of PMS, a set of non-pharmacologic treatments is recommended before pharmacologic treatment. Patients can be benefited from non-pharmacological treatments such as patient education, cognitive therapy, behavioral therapy, and dietary supplementation. Pharmacologic therapy including psychotropic agents, diuretics, and prostaglandin inhibitors may be used, when PMS symptoms are not sufficiently improved after non-pharmacologic treatments, or when symptoms fit the diagnostic criteria of premenstrual dysphoric disorder(PMDD). When treatment fails, hormonal therapy to manipulate menstrual cycle may be considered, and several trials showed improvement of physical and mood symptoms.

Keyword

Premenstrual syndrome; Non-pharmacologic treatment; Pharmacologic treatment

MeSH Terms

Cognitive Therapy
Dietary Supplements
Diuretics
Female
Humans
Menstrual Cycle
Patient Education as Topic
Premenstrual Syndrome*
Prostaglandin Antagonists
Diuretics
Prostaglandin Antagonists